Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-017995

Kezar Life Sciences, Inc. · KZR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jun 25, 2018
Accepted (ET)
Jun 25, 2018 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645666

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 25, 2018C315,489$0.00A315,489D
Common StockF1,F2Jun 25, 2018C315,489$0.00A315,489IBy Omega IV
Common StockF3Jun 25, 2018C377,783$0.00A693,272D
Common StockF3,F2Jun 25, 2018C377,783$0.00A693,272IBy Omega IV

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Redeemable Convertible Preferred StockF1—Jun 25, 2018C315,489D——Common Stock315,4890D
Series A Redeemable Convertible Preferred StockF2,F1—Jun 25, 2018C315,489D——Common Stock315,4890I
Series B Redeemable Convertible Preferred StockF3—Jun 25, 2018C377,783D——Common Stock377,7830D
Series B Redeemable Convertible Preferred StockF2,F3—Jun 25, 2018C377,783D——Common Stock377,7830I

Explanation of responses